Impaired granzyme B-producing regulatory B cells in systemic lupus erythematosus

2021 ◽  
Vol 140 ◽  
pp. 217-224
Author(s):  
Mingxin Bai ◽  
Liling Xu ◽  
Huaqun Zhu ◽  
Jimeng Xue ◽  
Tian Liu ◽  
...  
2010 ◽  
Vol 40 (7) ◽  
pp. 2060-2069 ◽  
Author(s):  
Magdalena Hagn ◽  
Verena Ebel ◽  
Kai Sontheimer ◽  
Elisabeth Schwesinger ◽  
Oleg Lunov ◽  
...  

PLoS ONE ◽  
2014 ◽  
Vol 9 (2) ◽  
pp. e88441 ◽  
Author(s):  
Xue Yang ◽  
Ji Yang ◽  
Yiwei Chu ◽  
Yu Xue ◽  
Dandan Xuan ◽  
...  

2014 ◽  
Vol 66 (10) ◽  
pp. 2849-2861 ◽  
Author(s):  
Nele Gao ◽  
Julia Dresel ◽  
Volker Eckstein ◽  
Rimma Gellert ◽  
Hannah Störch ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Zhuang Ye ◽  
Yanfang Jiang ◽  
Dejun Sun ◽  
Wei Zhong ◽  
Ling Zhao ◽  
...  

Abstract Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease that is associated with the destruction of immune tolerance and activation of B cells. Interleukin (IL)-35 and IL-35-producing (IL-35+) regulatory B cells (Bregs) have been demonstrated to possess immunosuppressive functions, but their roles in the initiation and early development of SLE have not been explored. Here, we measured and compared the frequencies of blood regulatory B cell subsets and the concentrations of plasma IL-35, IL-10, IL-17A, tumor necrosis factor (TNF)-α, and interferon (IFN)-γ in 47 Chinese patients with newly diagnosed SLE and 20 matched healthy controls (HCs). The SLE patients had decreased percentages of IL-35+ B cells and IL-10+ B cells among the total blood B cells as well as decreased concentrations of plasma IL-35. In addition, higher levels of plasma IL-10, IFN-γ, TNF-α, and IL-17 along with higher frequencies of circulating plasma and memory B cells were observed in the SLE patients. The percentage of IL-35+ Bregs and the serum IL-35 level were inversely correlated with the SLE disease activity index and the erythrocyte sedimentation rate (ESR) levels. Our results indicate that IL-35+ Bregs and IL-35 may play protective roles in SLE initiation and progression.


2019 ◽  
Vol 2019 ◽  
pp. 1-7 ◽  
Author(s):  
Tao Wang ◽  
Yongjun Mei ◽  
Zhijun Li

Systemic lupus erythematosus (SLE) is a chronic, systemic, autoimmune inflammatory disease characterized by the production of numerous autoantibodies and cytokines, as well as multiple organ damage. Specific B cell subsets negatively regulate immune responses and have been termed regulatory B cells (Bregs). Bregs are characterized by the production of the immunoregulatory cytokines interleukin (IL)-10, IL-35, and transforming growth factor (TGF)-β. Bregs suppress other immune cells through the secretion of these immunosuppressive cytokines and have thus been studied extensively for their potential role in the treatment of various autoimmune diseases. The progress of the research on Bregs and SLE in recent years is reviewed in this paper.


Sign in / Sign up

Export Citation Format

Share Document